452 related articles for article (PubMed ID: 32369451)
1. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
[TBL] [Abstract][Full Text] [Related]
2. Impact of house dust mite in vitiligo skin: environmental contribution to increased cutaneous immunity and melanocyte detachment.
Bzioueche H; Boniface K; Drullion C; Marchetti S; Chignon-Sicard B; Sormani L; Rocchi S; Seneschal J; Passeron T; Tulic MK
Br J Dermatol; 2023 Aug; 189(3):312-327. PubMed ID: 37140010
[TBL] [Abstract][Full Text] [Related]
3. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
4. Fas-FasL interaction in cytotoxic T cell-mediated vitiligo: The role of lesional expression of tumor necrosis factor-α and interferon-γ in Fas-mediated melanocyte apoptosis.
Jimbo H; Nagai H; Fujiwara S; Shimoura N; Nishigori C
Exp Dermatol; 2020 Jan; 29(1):61-70. PubMed ID: 31675451
[TBL] [Abstract][Full Text] [Related]
5. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.
Moretti S; Fabbri P; Baroni G; Berti S; Bani D; Berti E; Nassini R; Lotti T; Massi D
Histol Histopathol; 2009 Jul; 24(7):849-57. PubMed ID: 19475531
[TBL] [Abstract][Full Text] [Related]
7. Aberrant ETS-1 signalling impedes the expression of cell adhesion molecules and matrix metalloproteinases in non-segmental vitiligo.
Srivastava N; Bishnoi A; Mehta S; Rani S; Kumar R; Bhardwaj S; Sendhil Kumaran M; Keshavamurthy V; Gupta S; Parsad D
Exp Dermatol; 2020 Jun; 29(6):539-547. PubMed ID: 32350934
[TBL] [Abstract][Full Text] [Related]
8. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo.
Gauthier Y; Cario-Andre M; Lepreux S; Pain C; Taïeb A
Br J Dermatol; 2003 Jan; 148(1):95-101. PubMed ID: 12534601
[TBL] [Abstract][Full Text] [Related]
9. Expression of discoidin domain receptor 1 and E-cadherin in epidermis affects melanocyte behavior in rhododendrol-induced leukoderma mouse model.
Abe Y; Hozumi Y; Okamura K; Suzuki T
J Dermatol; 2020 Nov; 47(11):1330-1334. PubMed ID: 32770866
[TBL] [Abstract][Full Text] [Related]
10. Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo.
Singh M; Mansuri MS; Kadam A; Palit SP; Dwivedi M; Laddha NC; Begum R
Cytokine; 2021 Apr; 140():155432. PubMed ID: 33517195
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligo.
Willemsen M; Krebbers G; Tjin EPM; Willemsen KJ; Louis A; Konijn VAL; Narayan VS; Post NF; Bakker WJ; Melief CJM; Bekkenk MW; Luiten RM
Exp Dermatol; 2022 Apr; 31(4):556-566. PubMed ID: 34758170
[TBL] [Abstract][Full Text] [Related]
12. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions.
Moretti S; Spallanzani A; Amato L; Hautmann G; Gallerani I; Fabiani M; Fabbri P
Pigment Cell Res; 2002 Apr; 15(2):87-92. PubMed ID: 11936274
[TBL] [Abstract][Full Text] [Related]
13. Targeting the elevated IFN-γ in vitiligo patients by human anti- IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte.
Ng CY; Chan YP; Chiu YC; Shih HP; Lin YN; Chung PH; Huang JY; Chen HK; Chung WH; Ku CL
J Dermatol Sci; 2023 Jun; 110(3):78-88. PubMed ID: 37221109
[TBL] [Abstract][Full Text] [Related]
14. Melanocyte Adhesion and Apoptosis in Vitiligo: Linking Puzzle Blocks.
Srivastava N; Gupta S; Parsad D
Curr Mol Med; 2023; 23(8):709-711. PubMed ID: 35726816
[TBL] [Abstract][Full Text] [Related]
15. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo.
Kumar R; Parsad D; Kanwar AJ; Kaul D
Br J Dermatol; 2011 Aug; 165(2):285-91. PubMed ID: 21428970
[TBL] [Abstract][Full Text] [Related]
16. Melanocyte-keratinocyte cross-talk in vitiligo.
Touni AA; Shivde RS; Echuri H; Abdel-Aziz RTA; Abdel-Wahab H; Kundu RV; Le Poole IC
Front Med (Lausanne); 2023; 10():1176781. PubMed ID: 37275386
[TBL] [Abstract][Full Text] [Related]
17. A New View of Vitiligo: Looking at Normal-Appearing Skin.
Picardo M; Bastonini E
J Invest Dermatol; 2015 Jul; 135(7):1713-1714. PubMed ID: 26066890
[TBL] [Abstract][Full Text] [Related]
18. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?
Gauthier Y; Cario Andre M; Taïeb A
Pigment Cell Res; 2003 Aug; 16(4):322-32. PubMed ID: 12859615
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of tenascin-C in vitiligo.
Abdou AG; Maraee AH; Shoeib MA; Elbana R
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
